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ABSTRACT
Background. The German National Health Interview and Examination Survey (GHS) is the first
government mandated nationwide study to investigate jointly the prevalence of somatic and
mental disorders within one study in the general adult population in Germany. This paper reports
results from its Mental Health Supplement (GHS-MHS) on 4-week 12-month, and selected life-
time prevalence of a broad range of DSM-IV mental disorders, their co-morbidity and correlates in
the community.
Methods. The sample of the GHS-MHS (n=4181; multistage stratified random sample drawn
from population registries ; conditional response rate : 87.6%) can be regarded as representative for
the German population aged 18–65. Diagnoses are based on fully structured computer assisted
clinical interviews (M-CIDI), conducted by clinically trained interviewers.
Results. 12-month prevalence for any DSM-IV study disorder is 31% (lifetime: 43%; 4-week:
20%) with anxiety disorders, mood disorders and somatoform syndromes being the most frequent
diagnoses. Retrospective age of onset information reveals that most disorders begin early in life.
Comorbidity rates among mental disorders range from 44% to 94%. Correlates of increased rates
of mental disorders and co-morbidity were: female gender (except for substance disorders), not
being married, low social class, and poor somatic health status. Health care utilization for mental
disorders depended on co-morbidity (30% in ‘pure’, 76% in highly co-morbid cases) and varied
from 33% for substance use disorders to 75% for panic disorder.
Conclusions. Results confirm and extend results from other national studies using the same
assessment instruments with regard to prevalence, co-morbidity and sociodemographic correlates,
covering a broader range of DSM-IV disorders [i.e. somatoform disorders, all anxiety disorders
(except PTSD), mental disorders due to substance or general medical factor, eating disorders].
Intervention rates were higher than in previous studies, yet still low overall.
INTRODUCTION
Historically, despite some notable regional
exceptions (e.g. Iceland; Hagnell, 1970), there
have been only few nationally representative
community surveys on the prevalence of mental
disorders before the 1980s and those available
revealed tremendous variation in findings
(Weissman et al. 1993). This has been explained
by various factors, including: the misconception
that mental disorders are fairly infrequent
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phenomena, the lack of reliable diagnostic cri-
teria and diagnostic instruments, the almost
exclusive focus on broad diagnostic categories
of severe psychotic and neurotic disorders, the
lack of efficient treatments and the lack of a
broader spectrum of mental health services.
Parallel to the introduction of explicit diagnos-
tic criteria for specific forms of mental disorders
in the DSM-III (APA, 1980), and subsequent
to the landmark Epidemiological Catchment
Area study (ECA; Regier et al. 1984; Robins &
Regier, 1990) in 1980, this situation changed
considerably. The ECA not only demonstrated
that mental disorders can be assessed using
standardized diagnostic interviews with a simi-
lar level of reliability, validity and accuracy as
the assessment in surveys of somatic disorders,
but also suggested that the risk of developing
mental disorders in adolescence and over a
lifetime, as well as the current prevalence
and co-morbidity had been heavily under-
estimated.
Continuing interest in mental disorders has
prompted the conduct of numerous nationwide
mental health surveys, which have shown fairly
convergently and with increasing sophistication
that mental disorders affect at least one third of
population over their lifetime and at least about
one fifth in the past month. Examples include
the Munich Follow-up Study in former West
Germany (Wittchen, 1988), subsequent reanaly-
ses of the Cross-National Collaborative Group
(e.g. Weissman et al. 1996), the National Co-
morbidity Survey in the USA (NCS; Kessler
et al. 1994), the Australian National Mental
Health Survey (ANMHS; Andrews et al. 2001),
the National Psychiatric Morbidity Surveys of
Great Britain (NPMS; Jenkins et al. 1997), The
Netherlands Mental Health Survey and Inci-
dence Study (NEMESIS; Bijl et al. 1998), and
more recently several other countries around
the world that have been involved in the cross
national comparative studies of the WHO
International Consortium in Psychiatric Epi-
demiology (Andrade et al. 2000).
Despite these developments, numerous criti-
cal and unresolved issues still make it difficult to
draw firm conclusions about the size and scope
of mental disorders, their associated correlates
and consequences which could potentially pro-
vide guidance for health care planning. These
include the following considerations.
(1) Even though the majority of epidemi-
ological studies made use of the same diagnostic
instrument to obtain diagnoses according to
the criteria of DSM-III-R and IV (APA, 1987,
1994), the Diagnostic Interview Schedule (DIS;
Robins et al. 1981) and its successor, the
Composite International Diagnostic Interview
(CIDI; WHO, 1997), there is still substantial
and sometimes confusing variation in findings
(even more when different diagnostic instru-
ments are used).
(2) Some variations can be explained by
design issues: the prevalence of mental disorders
has been shown to differ by age groups and age
cohort, thus the year the study was conducted
and the age range of the sample is of relevance.
(3) Almost all studies made at least some
modification in their assessment instrument, by
either adding diagnoses, omitting diagnoses,
changing diagnostic thresholds or algorithms,
changing the order of sections, adding questions
on impairment and help-seeking or dimensional
measures; other important sources of variance
might result from the use of lay or alternatively
clinical interviewers. All of these modifications
have been shown to have potentially significant
effects on prevalence estimates as well as co-
morbidity figures (Brugha et al. 1999; Wittchen
et al. 1999a).
(4) A critical issue for health care policy
decisions and implications derived from such
studies is either lack or inconsistency of evalu-
ation of disability and severity as well as help-
seeking behaviour associated with mental
disorders. Such considerations are of major im-
portance for health care planners to determine
met and unmet needs appropriately for different
target groups. This problem is particularly evi-
dent in prevalence estimates of studies based
on the lifetime version of the DIS or CIDI. The
lifetime version of the CIDI ascertains primarily
whether the diagnostic criteria are met at some
point in the respondent’s life and then asks for
the first (onset) and last occurrence (recency
codes) of at least some of the core features of
the respective diagnosis. In these studies, current
prevalence estimates merely indicate that the
person had the diagnosis in the past and still has
some symptoms without necessarily determining
that the person meets the full set of diagnostic
criteria. For health care purposes and need
estimations, however, this type of diagnostic
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cross-sectional information is crucial, especially
in conjunction with information on associated
impairment, disability and help-seeking behav-
iour in order to make an appropriate evaluation
of need.
Against this background, in 1997 the German
government commissioned a comprehensive
nationwide morbidity and health survey in the
community to describe in a coordinated study
the prevalence of somatic and mental disorders
in the adult German population. This project is
unique in two respects : it is the first nationwide
mental health survey in Germany and also the
first survey in which somatic and mental dis-
orders were both rigorously assessed within one
study, using reliable structured somatic and psy-
chiatric interviews in a representative national
sample. Particular requirements for the mental
health survey were: (1) a broad coverage of
specific mental disorders, including all substance
use and anxiety disorders (except PTSD) and
previously neglected disorders like somatoform
and eating disorders, as well as disorders due to
substance and general medical factors, (2) the
provision of predominantly strict 12-month
estimates for symptoms and diagnoses of mental
disorders in order to allow for the examination
of associations with physical morbidities as-
sessed for the same time frame and to make
comparative analyses between disorders with
regard to disabilities, quality of life and health
service utilization.
This paper reports the basic prevalence find-
ings of the GHS-MHS, focusing on four aims:
(1) to report 12-month and selected 1-month
and lifetime prevalence estimates and associated
correlates of mental disorders in a nationally
representative sample, including information
on ages of onset ; (2) to determine the degree
of co-morbidity between mental disorders; (3)
to determine associations between mental dis-
orders, co-morbidity and treatment utilization,
and (4) to report associated correlates of dis-
orders and co-morbidity.
METHODS
Aims, design and methods have been recently
described in greater detail in a separate publi-
cation (Jacobi et al. 2002). Therefore, design
and sample characteristics are discussed only
briefly here.
Design and sample
Mental disorders were assessed in the Mental
Health Supplement of the German National
Health Interview and Examination Survey
(GHS-MHS) in a subsample of its core sur-
vey (GHS-CS; Bellach et al. 1998). The core
survey covered a range of medical and social
assessments and was administered between
June 1998 and October 1999. Its sample was a
stratified random sample from 113 communities
throughout Germany with 130 sampling units
(sampling steps: 1, selection of communities ; 2,
selection of sampling units ; and 3, selection of
inhabitants). The sample was drawn from the
population registries of subjects aged 18–79
living in Germany in the year 1997. As a result
a gross sample of 13 222 people were eligible,
representative according to the age, sex and
community type criteria. The response rate
(completing the total assessment in the GHS-
CS) was 61.4% (n=7124). The response rate
including subjects completing parts of the
assessment was 77.8%. Reasons for non-
participation, analyses of non-response, and
further information on sample and weighting
in the GHS-CS are provided elsewhere (Thefeld
et al. 1999).
For financial and logistical reasons the data
for mental disorders were gathered using a two-
stage design. The first stage entailed the admin-
istration of a 12-item screening questionnaire
for mental disorders at the end of the medical
examination of the core survey [CID-S; sensi-
tivity for any 12-month diagnosis (‘caseness’) :
85.3%, specificity: 55.3%, positive predictive
value: 38.3%, negative predictive value : 92.0%;
Wittchen et al. 1999b].
The second stage involved the separate ad-
ministration of a complete, structured, clinical
psychopathological interview to all core survey
respondents who had been screened positive for
a mental disorder and to a random sample of
50% who had been screened negative. Due to
the resulting oversampling of screen positives,
data were weighted in the later analyses. In order
to adjust the net sample to German age, sex and
community distribution, data were also weigh-
ted for age, sex, and region corresponding to the
national administrative statistics of December
1997. The presented weighted results can be
regarded as representative for the German
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non-instutionalized adult population from 18 to
65 years of age with sufficient language skills
to follow the interviews. Hospitalized patients
who were hospitalized throughout the recruit-
ment phase (0.5–0.8% of the target population
in the sample points) were only omitted if they
were in institutions during the entire recruitment
period. Therefore it is unlikely that this ex-
clusion criterion might have an effect on the re-
ported prevalences. Respondents of the German
Health Survey older than 65 years were ex-
cluded because the psychometric properties
of the CIDI, the interview used in the study,
have not yet been satisfactorily established for
use in older populations (Knäuper & Wittchen,
1994).
After exclusion of the subjects older than 65
and 50% of the screen negatives, the eligible
sample size for the GHS-MHS was n=4773.
The conditional response rate of the GHS-MHS
was 87.6%, resulting in a total of 4181 respon-
dents who completed the mental health assess-
ment. Sociodemographic variables of the sample
are shown in the first column of Table 3.
Assessment
We present DSM-IV prevalences because (1)
their operationalization in terms of criteria is
more straightforward and (2) the validity of
ICD-10 diagnostic criteria for research (ICD-
10-DCR) has never been established for the
CIDI. ICD-10 compatible codes can easily be
derived from the coding rules for ‘translation’
from DSM-IV.
Psychopathological and diagnostic assess-
ments were based on the computer-assisted
version of the Munich Composite Internat-
ional Diagnostic Interview (DIA-X/M-CIDI;
Wittchen & Pfister, 1997), a modified version of
the World Health Organization CIDI (version
2.1 ; WHO, 1997) for a wider range of mental
disorder according to the criteria of DSM-IV
than previous studies.
Unlike previous versions of the CIDI, the
study version focuses strictly on the assessment
of 12-month symptoms and disorders. The stan-
dard CIDI lifetime assessment was only per-
formed when lifetime information was necessary
for evaluating current diagnoses (e.g. mood
disorders).
Psychometric properties of the CIDI were
found to range from acceptable to very good
(Wittchen, 1994; Lachner et al. 1998; Reed
et al. 1998). The interviewers (n=24, mostly
psychologists who had already worked on
other CIDI studies) had received a 3-day CIDI
training session for the GHS-MHS and CIDI
refresher courses every 3 months throughout
the field period. They conducted on the average
174 interviews in eight sampling units and
were closely monitored and provided with feed-
back by trained M-CIDI clinical editors who
regularly checked all interviewers according to a
standard procedure. In a final quality control
only eight interviews had to be eliminated due to
missing or inconsistent datasets (Jacobi et al.
2002).
The following mental disorders according to
DSM-IV were included: mental disorders due
to general medical condition; schizophrenia and
possible psychotic disorders (screening without
further differential diagnosis) ; substance use
disorders (dependence and abuse of alcohol,
illicit substances, and nicotine) ; mood disorders
(unipolar and bipolar) ; anxiety disorders (in-
cluding obsessive compulsive disorder; with-
out PTSD), somatoform disorders (including
the abridged somatization syndrome SSI4.6;
Escobar et al. 1989; without conversion and
body dysmorphic disorder) ; and eating dis-
orders. Unfortunately, we were not com-
missioned to include post-traumatic stress
disorder and antisocial personality (as for ex-
ample in the NCS) because of time and financial
restrictions. Subthreshold diagnoses could be
assessed as well (Carter et al. 2001). Health care
utilization is presented in form of the variable
‘at least minimal intervention’, a combination
of items asking about having ever sought treat-
ment due to psychological, mental, addictive or
psychosomatic problems, or been recommended
by a doctor to do so.
Analytic strategy
Presented prevalence estimates (n, %, S.E.) were
calculated with the data weighted for age,
gender, region and screening status in order to
address different sampling probabilities and
systematic non-response. Logistic regression
(odds ratios and 95% confidence intervals) were
used to quantify the associations between men-
tal disorders and their correlates.
Age and sex were adjusted for in each analysis
to control for different base distributions of
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prevalence and co-morbidity within the sample.
To account for the weighting scheme as well
as the stratified sampling design by screening
status, statistical inference (standard errors,
confidence intervals and p values) was based on
the Huber–White sandwich estimator of vari-
ance (Woodruff, 1971; Binder, 1983; Royall,
1986). This was done with the Stata software
package, release 7.0 (StataCorp, 2001).
RESULTS
Table 1 shows CIDI/DSM-IV prevalence esti-
mates and corresponding standard errors of a
range of selected lifetime, 12-month, and 4-week
disorders (or aggregated diagnostic categories)
assessed in the GHS-MHS.
Overall prevalences
About 20% of the sample reported at least one
of the listed disorders in Table 1 in the past
4 weeks, 31% had one or more disorders in the
12 months before the interview and a total of
43% had a lifetime history of at least one of the
selected DSM-IV disorders.
Diagnostic groups
As an aggregated category, anxiety disorders
were more prevalent (4-week and 12-month, life-
time not assessed) than somatoform disorders/
syndromes and mood disorders which show
comparable prevalence numbers : in the pre-
vious 12 months one in every seven respondents
had fulfilled the criteria for an anxiety disorder,
and about one of every 10 respondents had suf-
fered from a mood or somatoform disorder/
syndrome. Substance use disorders (without
nicotine) in the previous 12 months were diag-
nosed in about one in every 20 participants.
A considerable number met criteria of the
M-CIDI psychosis screen (4-week: 1.5%;
12-month: 2.6%; lifetime: 4.5%). This count
includes about equal proportions of subjects
with mood congruent or incongruent psychotic
features occurring exclusively in the course of
depressive or bipolar disorders, and subjects re-
porting psychotic symptoms of varying duration
occurring at other times. M-CIDI syndrome
information for psychotic disorders do not allow
for the derivation of specific diagnoses of psy-
chotic disorders such as schizophrenia.
The least prevalent diagnoses were mental
disorders due to a general medical condition
(4-week: 0.5%; 12-month: 1.3%) and eating
disorders (4-week: 0.2%; 12-month: 0.3%).
(Aggregated) subdiagnoses
Themost commonmental disorders were phobic
disorders (4-week: 7.4%; 12-month: 12.6%;
lifetime not assessed), depressive disorders
(4-week: 5.6%; 12-month: 10.7%; lifetime:
17.1%), and somatoform pain disorder (4-week:
5.4%; 12-month: 8.1%; lifetime: 12.7%).
The next most common disorders were
alcohol abuse or dependence (4-week: 2.5%;
12-month: 4.1%; lifetime: 8.5%) and the
subthreshold somatization disorder SSI4.6
(Escobar et al. 1989; 4-week: 3.1%; 12-month:
4.3%; lifetime: 5.6%).
Gender differences
As in previous epidemiological studies men fulfil
diagnostic criteria for mental disorders less
often than women. The only exceptions are
substance use disorders, where men have con-
siderably higher prevalence rates than women
(especially alcohol abuse or dependence), and
possible psychotic disorders (distributed equally
among men and women). In addition, women
seem more likely than men to suffer from co-
morbid mental disorders (4-week: 40.3%
v. 30.3%; 12-month: 43.7% v. 33.5%; lifetime:
48.7% v. 35.7%; not shown in Table 1).
Ages of onset
In the GHS-MHS, ages of onset were assessed
retrospectively. Figure 1 shows the cumulative
distribution of age of onset for selected dis-
orders [note: for anxiety disorders (except panic
disorders) ages of onset were only assessed in
subjects with a 12-month diagnosis].
Most mental disorders develop in adolescence
and early adulthood, reaching the median of life-
time disorders by the age of 20 (anxiety, bipolar
mood, somatoformand substanceuse disorders).
Depressive disorders and possible psychotic
disorders tend to emerge later (median=31
years/37 years). The range between the 25th
and the 75th percentile of the age of onset is
lowest in substance and bipolar disorders, where
over 75% begin before the age of 30 and
prevalence drops sharply in respondents older
than 30.
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Table 1. Prevalences of mental disorders (4-week, 12-month and lifetime M-CIDI/DSM-IV) in the general population
(GHS-MHS ; n=4181)a
Disorders (DSM-IV)
4-week 12-month Lifetime
Total
Male Female
Total
Male Female
Total
Male Female
nj % (S.E.)k % (S.E.) % (S.E.) n % (S.E.) % (S.E.) % (S.E.) n % (S.E.) % (S.E.) % (S.E.)
Any mental disorder due to general medical condition 19 0.5 (0.1) 0.4 (0.1) 0.6 (0.1) 56 1.3 (0.2) 0.8 (0.2) 1.9 (0.3) 94 2.3 (0.2) 1.8 (0.3) 2.7 (0.4)
Any substance disorderb 119 2.9 (0.3) 4.4 (0.5) 1.3 (0.3) 188 4.5 (0.3) 7.2 (0.6) 1.7 (0.2) 414 9.9 (0.6) 15.6 (0.9) 4.2 (0.4)
Alcohol abuse/dependence 104 2.5 (0.3) 4.0 (0.5) 0.9 (0.2) 170 4.1 (0.3) 6.8 (0.6) 1.3 (0.2) 355 8.5 (0.5) 14.4 (0.9) 2.6 (0.3)
Any illicit substance abuse/dependence 21 0.5 (0.1) 0.6 (0.2) 0.4 (0.1) 30 0.7 (0.1) 1.0 (0.2) 0.5 (0.1) 90 2.1 (0.2) 2.3 (0.3) 1.9 (0.3)
Possible psychotic disorderc 61 1.5 (0.2) 1.6 (0.3) 1.3 (0.2) 107 2.6 (0.3) 2.6 (0.4) 2.5 (0.3) 189 4.5 (0.4) 4.1 (0.5) 5.0 (0.5)
Any mood disorderd 262 6.3 (0.4) 4.8 (0.5) 7.8 (0.6) 499 11.9 (0.5) 8.5 (0.7) 15.4 (0.8) 779 18.6 (0.6) 12.3 (0.8) 25.0 (1.0)
Any unipolar depression 223 5.6 (0.4) 4.2 (0.5) 6.9 (0.6) 448 10.7 (0.5) 7.5 (0.6) 14.0 (0.8) 716 17.1 (0.6) 11.1 (0.8) 23.3 (0.9)
Any bipolar disorder 23 0.6 (0.1) 0.3 (0.1) 0.8 (0.2) 34 0.8 (0.1) 0.6 (0.1) 1.1 (0.2) 42 1.0 (0.1) 0.8 (0.2) 1.2 (0.2)
Any anxiety disordere 375 9.0 (0.4) 5.3 (0.5) 12.7 (0.7) 604 14.5 (0.5) 9.2 (0.6) 19.8 (0.9)
Panic disorderf 47 1.1 (0.2) 0.9 (0.2) 1.3 (0.2) 98 2.3 (0.2) 1.7 (0.2) 3.0 (0.4) 162 3.9 (0.3) 2.2 (0.3) 5.5 (0.5)
Any phobiag 311 7.4 (0.4) 3.9 (0.4) 11.0 (0.7) 525 12.6 (0.6) 7.5 (0.6) 17.7 (1.0)
Generalized anxiety disorder 50 1.2 (0.2) 0.9 (0.2) 1.5 (0.3) 64 1.5 (0.2) 1.0 (0.2) 2.1 (0.3)
Obsessive compulsive disorder 18 0.4 (0.1) 0.2 (0.2) 0.6 (0.0) 30 0.7 (0.1) 0.6 (0.2) 0.9 (0.2)
Any somatoform disorder/syndromeh 311 7.5 (0.4) 4.9 (0.5) 10.0 (0.7) 461 11.0 (0.6) 7.1 (0.6) 15.0 (0.8) 678 16.2 (0.7) 10.3 (0.8) 22.2 (1.0)
SSI4.6 128 3.1 (0.3) 2.2 (0.3) 3.9 (0.5) 181 4.3 (0.3) 3.1 (0.4) 5.5 (0.6) 235 5.6 (0.4) 3.9 (0.4) 7.3 (0.6)
Pain disorder 227 5.4 (0.4) 3.4 (0.4) 7.5 (0.6) 340 8.1 (0.5) 4.9 (0.5) 11.4 (0.7) 533 12.7 (0.5) 7.8 (0.6) 17.8 (0.9)
Any eating disorderi 8 0.2 (0.0) 0.1 (0.0) 0.3 (0.1) 14 0.3 (0.1) 0.2 (0.1) 0.5 (0.2) 33 0.8 (0.1) 0.3 (0.1) 1.3 (0.3)
Any of the above 829 19.8 (0.6) 15.8 (0.9) 23.9 (1.0) 1301 31.1 (0.8) 25.3 (1.1) 37.0 (1.1) 1791 42.6 (0.8) 36.8 (1.2) 48.9 (1.1)
a Weighted data; DSM-IV hierarchy rules were dropped; age distributions and confidence intervals available on request.
b Abuse or dependence (without nicotine).
c Screening for Schizophrenia and other psychotic disorders without further differential diagnosis ; includes psychotic features occurring as part of mood disorders.
d Major Depressive Disorder, Dysthymic Disorder, Bipolar I Disorders, Bipolar II Disorders, single hypomanic episode; unipolar and bipolar mood disorders do not add up to 100%
because single hypomanic episode was not included in either category.
e For anxiety disorders (including Obsessive Compulsive Disorder, excluding Post-traumatic Stress Disorder) no lifetime diagnoses except for panic disorders available.
f With or without Agoraphobia.
g Agoraphobia without history of Panic Disorder, Social Phobia, Specific Phobias (animal, natural environment, blood-injection-injury, and situational type), Anxiety Disorder NOS.
h Somatization Disorder, Undifferentiated Somatization Disorder, Somatic Symptom Index SSI4.6, Hypochondriasis, Pain Disorder.
i Anorexia Nervosa, Atypical Anorexia Nervosa, Bulimia Nervosa, Atypical Bulimia Nervosa.
j Weighted numbers ; numbers of single diagnoses exceed numbers of aggregated groupings if comorbid.
k Weighted percentages and standard errors.
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Co-morbidity
Table 2 reveals rates for 12-month co-mor-
bidity. 60.5% of the diagnosed subjects had a
single diagnosis and 39.5% were co-morbid (4-
week: 36.3%; lifetime: 43.1%; not shown in
Table 2). 10.3% were highly co-morbid (>3
disorders; 4-week: 10.3%; lifetime: 10.5%; not
shown in Table 2). It has to be mentioned
that these results on co-morbidity are cross-
sectional. Taking lifetime co-morbidity into
account, the co-morbidity rate of respondents
with a given 4-week diagnosis is shifted from
36% to 64% and for 12-month diagnoses from
39% to 53% (not shown in Table 2).
Table 2, left section, shows proportions
of ‘pure’ disorders and one/two/three or more
additional diagnoses per disorder. A total of
2321 diagnoses were assigned to the 1301 re-
spondents with at least one disorder. Pure
disorders in the past 12 months were quite
rare.Only 786 12-month diagnoses assignedwere
pure, whereas 1327 diagnoses were co-morbid
(mean over all diagnoses: 66%). Proportions of
co-morbidity (at least one co-morbid condition)
ranged from 44% for alcohol abuse/dependence
to 94% for generalized anxiety disorder. The
rate for highly co-morbid disorders (>3 dis-
orders) was lowest in substance use disorders
(12.9–14.4%) and highest in possible psychotic
disorder (40%), panic disorder (49%), general-
ized anxiety disorder (53%) and obsessive
compulsive disorder (63%).
We also determined the most frequent combi-
nations of seven aggregated diagnostic groups
[any substance use disorder, any possible
psychotic disorder, any depressive disorder, any
bipolar disorder, any anxiety disorder, any
somatoform disorder, any eating disorder; 12-
month diagnoses] among the co-morbid cases
(n=514). Fifty-two different combinations out
of the logically possible 127 (27x1) occurred
at least one time, among them five relatively
frequent patterns that accounted for 60% of all
co-morbid patterns: depression-anxiety (19%),
anxiety-somatoform (12%), depressive-anxiety-
somatoform (11%), anxiety-anxiety (10%), and
depressive-somatoform (8%).
Health care utilization
Only 40% of respondents with at least one
12-month mental disorder received at least a
‘minimal intervention’ for their condition
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FIG. 1. Age of onset distributions.
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Table 2. Co-morbidity and health care utilization in subjects with at least one 12-month DSM-IV disordera
Disorders (DSM-IV)c
Proportions with Health care utilization: proportions of cases with at least minimal interventionb
Pure
disorder
%
One
additional
diagnosis
%
Two
additional
diagnoses
%
Three or more
additional
diagnoses
%
Total
%
Pure
disorder
%
One
additional
diagnosis
%
Two
additional
diagnoses
%
Three or more
additional
diagnoses
%
Any mental disorder due to general
medical condition
18.8 38.1 13.7 29.5 59.6 58.8 60.0 76.9 51.7
Any substance disorder 55.1 22.8 7.8 14.3 35.5 22.9 33.6 63.0 67.2
Alcohol abuse/dependence 55.7 23.3 6.7 14.4 34.4 22.3 36.2 56.7 68.1
Any illicit substance abuse/dependence 45.3 29.0 12.9 12.9 32.7 25.2 14.3 72.5 60.9
Possible psychotic disorder 27.1 19.8 13.3 39.9 56.6 30.3 45.1 50.1 82.4
Any mood disorder 38.8 21.8 15.7 23.7 52.5 41.0 40.6 61.6 76.2
Any depressive disorder 39.3 20.8 15.8 24.1 53.5 41.2 42.1 62.4 77.8
Any bipolar disorder 25.7 24.6 14.9 34.9 51.8 42.2 42.4 58.8 62.4
Any anxiety disorder 37.9 26.5 14.2 21.3 47.0 27.1 46.7 57.5 75.6
Panic disorder 11.7 26.9 12.4 49.0 75.4 54.3 51.4 79.0 92.6
Any phobia 39.8 25.4 13.7 21.2 45.3 25.2 45.7 56.4 75.7
Generalized anxiety disorder 6.4 15.5 24.7 53.3 68.8 55.6 69.1 56.1 76.2
Obsessive compulsive disorder 14.9 12.3 9.6 63.2 68.2 20.7 66.1 39.5 84.1
Any somatoform disorder/syndrome 45.7 21.2 14.7 18.5 42.5 27.2 42.4 53.9 71.3
SSI4.6 34.2 22.1 19.2 24.5 49.6 32.9 47.7 58.9 67.1
Pain disorder 43.5 22.0 14.7 19.7 40.0 25.0 35.6 51.7 69.6
Any eating disorder 34.8 21.1 30.8 13.3 47.0 49.1 — 85.2 27.5
Any mental disorder 60.5 20.3 9.0 10.3 40.5 30.6 43.5 59.6 76.1
a 2321 diagnoses were assigned to n=1301 respondents with at least one diagnosis out of n=4181 (total sample GHS-MHS).
b Health care utilization is presented in form of a variable ‘at least minimal intervention’, a combination of items asking for having ever been seeking treatment due to psychological, mental,
addictive or psychosomatic problems, or been recommended by a doctor to do so. The so-defined overall treatment rate was % in respondents with at least one diagnosis and % in respondents
with no diagnosis.
c For detailed information on included disorders see notes to Table 1.
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(having ever sought any kind of treatment due
to mental health problems or having been rec-
ommended by a doctor to do so). It should be
noted that if a co-morbid case was treated this
treatment is shown for every co-morbid disorder,
because in the present analysis it cannot be
determined for which disorder(s) this person was
treated; therefore numbers in Table 2 for specific
disorders exceed the overall participant’s treat-
ment rate (i.e. ‘anymental disorder ’). Treatment
rates increase fairly steadily by number of co-
morbid conditions. For example, in panic dis-
order, the most frequently treated disorder, 54%
of the pure and 93% of the highly co-morbid
cases report an at least minimal intervention.
Substance use disorders – the less frequently
treated disorders – show treatment rates from
23% (pure cases) to 67% (highly co-morbid
cases). Co-morbidity (in a model with sex, age
and three dummy variables for the number of
diagnoses) had the same predictive value (area
under the ROC curve=0.72) as the presence of
the different diagnoses (in a model with sex, age
and 12 dummies for the different diagnoses).
Correlates of mental disorders
Sociodemographic and health-related correlates
of 12-month disorders are shown in Table 3 with
odds ratios (OR) and confidence intervals (CI).
The significant sex differences have been
mentioned above: women have a lower risk of
having a substance use disorder (OR 0.2),
but a higher risk of having a mood disorder
(OR 2.0), an anxiety disorder (OR 2.4) or a
somatoform disorder (OR 2.3). Their average
number of diagnoses is about 70% higher than
inmen (not shown in Table 3). No sex differences
were found in possible psychotic disorders.
Age effects played only a minor role, except
for substance use disorders, where respondents
older than 34 years of age had significantly
fewer disorders than respondents aged 18–34
(35–49 years : OR 0.4; 50–65 years : OR 0.3).
Marital status is a significant correlate of
all mental disorders (except for somatoform dis-
orders) : being never married, separated, div-
orced or widowed increases the probability of
a diagnosis substantially (OR 1.5–2.9). The
separated/divorced or widowed respondents
have 80% more diagnoses than the married
ones (singles : 50% more diagnoses; not shown
in Table 3). Respondents from the lower social
class have significantly higher prevalences of
substance use disorders, mood disorders, and
anxiety disorders compared with a higher social
class (OR 0.5–0.8 for medium or upper social
class). With regard to somatoform disorders,
only the upper social class has a lower prevalence
rate than the low social class. Unemployed
and retired people in particular have elevated
risks for having a mental disorder (OR 1.5–2.3,
except for possible psychotic disorder, where
associations were slightly insignificant). So the
presented GHS-MHS data support the view
that rates of most mental disorders decline
with increasing social status. The social class
index used (Winkler–Schicht Index; Winkler
& Stolzenberg, 1998) is calculated from infor-
mation on education, current job status and
household net income; differential data on edu-
cation and employment status is also given in
Table 3.
Concerning physical illness (assessed by MDs
with a clinical structured computer assisted
interview; Jacobi et al. 2002), poor health status
is strongly associated with all mental disorders
(OR 1.9–4.0).
DISCUSSION
Design and sampling issues
This paper presents prevalence estimates of the
first nationwide German mental health survey
conducted after the reunification of former East
and West Germany and thus provides for the
first time ever comprehensive data about
the prevalence of mental disorders and their
burden in Germany. The conduct of this survey
as part of the regular national somatic health
survey is a significant step forward to an
integrated national health report system in
Germany. The joint assessment of mental
disorders and physical morbidities along with
data on disability, work disability, service util-
ization and treatment within one modular study
offers unique cross-comparisons between these
domains that will be dealt with in subsequent
steps of the analyses. Before highlighting the
major findings a few comments with regard to
design and methods will be given.
The high conditional response rate of almost
90% for the mental health supplement can
be regarded as satisfactory in light of the
non-response interview findings. Additional
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Table 3. Sociodemographic and health related correlates of major diagnostic subgroups and comorbidity (12-month)a
Distribution
of correlate
in sample
%
12-month prevalence if correlate present
Any substance
disorder
Any possible
psychotic disorder
Any mood
disorder
Any anxiety
disorder
Any somatoform
disorder
% ORb 95% CI % ORb 95% CI % ORb 95% CI % ORb 95% CI % ORb 95% CI
Sex
Men 50.3 7.2 2.6 8.5 9.2 7.1
Women 49.7 1.7 0.2* 0.2–0.3 2.6 1.0 0.7–1.5 15.4 2.0* 1.6–2.4 19.8 2.4* 2.0–3.0 15.0 2.3* 1.8–2.8
Age
18–34 34.5 7.7 2.9 11.3 13.9 10.2
35–49 34.0 3.5 0.4* 0.3–0.6 2.6 0.9 0.5–1.5 12.6 1.1 0.9–1.4 14.6 1.1 0.9–1.3 11.2 1.1 0.9–1.4
50–65 31.6 2.1 0.3* 0.2–0.4 2.2 0.7 0.5–1.2 11.8 1.0 0.8–1.3 14.9 1.1 0.9–1.3 11.7 1.2 0.9–1.5
Marital status
Married 64.1 2.7 2.0 9.8 13.2 10.6
Single 24.9 8.8 1.9* 1.2–3.1 3.6 1.8* 1.1–2.8 13.2 1.6* 1.2–2.3 15.1 1.4* 1.1–1.8 9.7 1.0 0.8–1.4
Separated/divorced/
widowed
11.0 5.6 2.9* 1.8–4.6 3.8 1.9 0.9–4.1 22.6 2.5* 1.9–3.3 20.2 1.5* 1.1–1.9 15.0 1.3 0.9–1.8
Employment statusc
Employed
Full time 49.8 4.7 2.6 9.1 10.8 9.0
15–34 h/week 8.1 2.3 1.5 0.7–3.3 0.8 0.3* 0.1–0.8 11.0 0.9 0.6–1.3 19.9 1.3 0.9–1.8 15.1 1.1 0.8–1.6
<15 h/week 4.8 0.5 0.4 0.1–2.6 0.5 0.2* 0.1–0.8 14.2 1.2 0.7–1.9 15.8 1.0 0.6–1.5 9.7 0.7 0.4–1.2
Not employed
Retired 9.7 3.0 1.9 0.9–4.4 1.6 0.6 0.3–1.6 16.3 2.1* 1.4–3.1 17.2 1.5* 1.1–2.2 13.8 1.4 0.9–2.1
School/student 5.7 10.3 1.7 0.9–3.0 3.8 1.4 0.7–3.1 12.1 1.2 0.7–1.9 12.2 1.0 0.6–1.6 7.2 0.7 0.4–1.2
Unemployed 6.5 6.3 2.0* 1.2–3.6 3.1 1.2 0.5–2.7 20.0 2.3* 1.6–3.2 23.2 2.2* 1.6–3.0 16.0 1.6* 1.1–2.4
Homemaker 7.2 0.7 0.6 0.1–2.6 4.1 1.6 0.7–3.4 17.8 1.5* 1.0–2.2 19.4 1.2 0.8–1.7 11.1 0.7 0.5–1.1
Social classd
Low 19.1 6.6 3.5 16.4 18.6 13.5
Medium 57.6 4.2 0.6* 0.4–0.9 2.4 0.7 0.4–1.1 12.0 0.7* 0.6–0.9 14.4 0.8* 0.6–0.9 10.6 0.8 0.6–1.0
High 23.3 3.7 0.6* 0.4–0.9 2.2 0.6 0.3–1.2 8.8 0.5* 0.4–0.7 11.3 0.6* 0.4–0.8 9.3 0.7* 0.5–0.9
Somatic health statuse
Good 29.3 4.9 1.7 7.5 10.1 5.3
Medium 45.4 4.7 1.4 0.9–2.1 2.5 1.6 0.9–3.0 12.0 1.6* 1.2–2.1 12.5 1.2 0.9–1.5 10.6 2.1* 1.5–2.8
Poor 24.7 3.6 1.9* 1.2–3.2 3.7 2.9* 1.7–5.0 17.2 2.5* 1.8–3.4 23.2 2.5* 1.9–3.3 18.8 4.0* 2.8–5.6
a GHS-MHS, weighted data, n=4181.
b Odds ratios (OR) from logistic regression and 95% confidence intervals (CI), controlled for age and sex; reference groups: not having the disorder under consideration ; * p<0.05.
c ‘Other ’ employment status (e.g. maternity leave, military or civil service) excluded from analyses.
d Index of social class (Winkler & Stolzenberg, 1998) derived from information on education, income and current (job) position.
e Crude indicator derived from the amount of somatic diseases assessed in the GHS-CS. Good: no somatic diseases within past 12 months; medium: 1–2 somatic diseases within past
12 months ; poor: 3 or more somatic diseases within past 12 months.
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checks for limited representativeness as com-
pared to the total population provided no evi-
dence for any major systematic sample bias
(Jacobi et al. 2002).
Retrospective data on age of onset are
notoriously unreliable, but may be useful in
the absence of other data. In the present cross-
sectional study, probes were embedded in the
interviews in order to reduce recall bias. Yet,
this cannot rule out systematic under-reporting
due to embarrassment or fear of discrimination
(Kessler, 2000).
We want to emphasize that this first preva-
lence publication reports predominantly diag-
nostically aggregated data. Findings on specific
subtypes and disorders will be dealt with in
separate follow-up publications.
Particular strengths of the study are as fol-
lows. (1) It is largely built on standardized
assessment instruments with an established re-
liability allowing for direct comparisons with
other studies. (2) It includes a considerably larger
number of specific mental disorders according
to DSM-IV criteria than previous studies. (3)
Unlike other community surveys using the same
instrument, we focused on 12-month and 4-week
estimates of symptoms and diagnoses of mental
disorders to increase precision and reliability and
to obtain straightforward 12-month symptom
counts. Lifetime disorders not present in the 12-
month were only assessed for mood, psychotic
and selected other disorders once the 12-month
assessment was completed. Not relying only
on recency information of lifetime diagnoses
when determining 12-month diagnoses provides
greater accuracy. Yet, the 12-month orientation
means that those without a current disorder are
less likely to report a lifetime disorder, resulting
in an over-representation of chronic cases with
an increased likelihood of early onset that has
to be considered in future analyses dealing with
lifetime diagnoses. (4) Interviews were conduc-
ted by clinically trained interviewers, since the
use of lay interviewers has often been mentioned
as a limitation of previous large-scale nationwide
surveys. This also allowed for the inclusion of
both psychotic syndromes, as well as general
medical factors.
Prevalence
Turning to the main findings, the study confirms
that mental disorders are highly prevalent,
affecting a substantial proportion of the adult
German population aged 18–65, with a total
12-month prevalence of 31%, a 4-week pre-
valence of 20% and a lifetime prevalence of
43%.
The GHS-MHS covers a relatively wide range
of more than 60 mental disorders, allowing for
a high degree of specification within seven
diagnostic groupings.
It is important to note that the rates of
morbidity shown in this study are not easily
comparable to findings from other community
studies due to different diagnostic criteria
(ICD-10 v. DSM-III-R v. DSM-IV), different
age ranges (e.g. higher prevalences of substance
use disorders in younger samples), and in
particular due to the inclusion of different diag-
noses. Some studies included additional diag-
noses (e.g. post-traumatic stress disorder and
antisocial personality in the NCS) or a more
restricted range of disorders (e.g. neglect of
somatoform disorders in most previous studies;
Faravelli et al. 1997). This selection has some
effect on the total prevalence estimated. Re-
garding the frequency of DSM-IV-disorders
in our study, as an example, the exclusion of
somatoform disorders lowers the overall life-
time prevalence fromabout 43% to 37% (mostly
due to 200 respondents with a pure somatoform
pain disorder).
Nevertheless our results show a relatively
strong concordance with most comparable
studies (e.g. those reported by Kessler et al.
1994; Bijl et al. 1998; Andrade et al. 2000;
Andrews et al. 2001). The overall 12-month
prevalence in the GHS-MHS is 31.1% for the
reported seven diagnostic DSM-IV groupings
(and 25.7% when excluding somatoform dis-
orders, eating disorders and mental disorders
due to a general medical condition which were
not assessed in most other studies). These rates
are comparable to the USA (29.5%), The
Netherlands (23.2%), most of the other ICPE
surveys (Brazil, Canada, Mexico, Turkey;
8.4–24.4%), and Australia (20.3%).
Rates for anxiety and mood disorders (14.5%
and 11.9%) are also relatively similar to the
USA (17.2% and 11.3%), slightly higher than
in The Netherlands (12.4% and 7.6%) and
most of the other ICPE surveys (4.0–12.4% and
4.2–7.1%), whereas in Australia remarkably
lower rates were found (5.6% and 6.6%).
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Substance use disorders were diagnosed less
often (4.5%, with the vast majority of alcohol
related disorders) than in the USA (11.3%),
The Netherlands (8.9%), most other ICPE
surveys (0.0–10.5%) and Australia (7.9%). As
mentioned above, when comparing these
rates internationally it is important to take into
account differences in the instruments (e.g. the
UM-CIDI in the NCS is particularly sensitive ;
Kessler et al. 2000), and age of the sample
(e.g. including only age 18–54 as in the NCS
the GHS-MHS prevalence of any substance
use disorder is shifted to 5.2%). Yet, the low
prevalence is surprising since alcohol consump-
tion, according to the WHO world drink trends
reports, is comparatively high in Germany. An
explanation could be the fact that diagnostic
criteria focus more on (culturally and socially
determined) inadequacy of drinking behaviour
than on absolute quantity of consumption.
Therefore, as an example, it is easier to qualify
for alcohol abuse in the USA where the con-
sumption of 1.5 litres of beer is labelled as
‘binge drinking’ compared to wide parts of the
German society, where this amount is consumed
several times a week without further negative
social consequences. In particular, young people
are more likely to receive a diagnosis of
alcohol abuse in the USA where drinking in
public is illegal until the age of 21 (Germany:
16 years).
Age of onset/persistence
The GHS-MHS findings also provide some fur-
ther evidence that most mental disorders begin
early. The median of the reported first onset
of anxiety, somatoform, bipolar mood and
substance use disorders is below 20 years of age.
The median of depressive disorders and possible
psychotic disorders is in young adulthood
(31 v. 37 years), and only about 25% of the af-
fected subjects develop their first disorder after
their early 40s. The different characteristics
match the average shapes of the cross-national
ICPE-results (Andrade et al. 2000). Data on age
of first onset were gathered retrospectively, and
information on the course of a disorder between
first onset and recent manifestation was not
assessed. Since we have no longitudinal data on
these issues, interpretations from this study on
course of disorders, longitudinal comorbid-
ity relevant for aetiological aspects of mental
disorders, or persistence are definitely limited.
However, there are some clues that might be
interpreted as indirect estimates of the chron-
icity of mental disorders. The average time
between reported age of onset and age of the
participants with the respective current diag-
nosis at the interview ranged from 10 to 20
years. Three quarters of all lifetime diagnoses
were still present in the last 12 months; the
prevalence ratios between time frames (4-week
12-month; 4-week lifetime; 12-month lifetime)
suggest that mental disorders are often stable
and call into question older statements that
mental disorders are characterized by high
remission rates.
Co-morbidity
We also confirmed that co-morbidity is a com-
mon phenomenon in almost all mental dis-
orders. By the way, this also appears to be true
for co-morbidity among somatic illnesses. Since
the patterns of co-morbidity are of a very com-
plex nature due to the coverage of the high
number of included disorders (Wittchen,
1996a, b), results on co-morbidity were pres-
ented in two relatively crude ways: number of
disorders per participant and amount of co-
morbidity per disorder. Regarding again the
12-month frame, about 40% of the diagnosed
participants have more than one single disorder.
In this context, it should be noted that co-mor-
bidity rates depend heavily on the definition of
co-morbidity. From the perspective of disorders,
a total of 2321 diagnoses were assigned to 1301
subjects. All disorders were highly to extremely
co-morbid, ranging from 44% (alcohol abuse/
dependence) to 88% (panic disorders) and 94%
(generalized anxiety disorder).
Health care utilization
Disregarding the noteworthy differences in base
rate probabilities of specific diagnoses, it is fair
to estimate that only about one third of pure
disorders receive at least a minimal health care
intervention, opposed to almost three out of
four highly co-morbid subjects. For each dis-
order, the presence of co-morbid disorders is
associated with a substantially higher rate of
help seeking. This is consistent with previous
findings from the USA and Canada (Kessler
et al. 1994; Merikangas et al. 1996). This
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replication in a German sample is remarkable,
yet discouraging, as we expected a higher treat-
ment rate due to the relatively well established
German mental health care system. Unlike the
USA and also to a lesser degree Canada, the
German health care system is characterized by a
fairly dense network of medical and psycho-
logical services that all provide mental health
care (including drugs and psychotherapy) free
of charge and without any major limitation of
access and treatment duration. Patients can even
bypass primary care physicians that usually
maintain a core gatekeeper function for special-
ized mental health care in most other countries.
Although we have no data in this study on
speed of treatment entry after developing the
first mental disorder, it appears that treatment
is only likely whenever the patient already has
developed complex co-morbid patterns. Future
analyses should examinewhether earlier targeted
treatment reduces co-morbidity and associated
burden in terms of disability and reduced qual-
ity of life.
Correlates
As in all comparable studies, women report
higher mental morbidity than men except for
substance use disorders (where men are diag-
nosed four times as frequently as women), and
possible psychotic disorders (where no sex dif-
ferences were found). There have been no sig-
nificant age effects on prevalence except for
substance use disorders (more frequent in
younger age).
Also, other correlates of mental disorders
are in line with existing knowledge (lower risk
for married, and for higher social class). How-
ever, findings of this kind are limited, since risk
factors of this sort are either not modifiable or
not specific enough for developing intervention
strategies (Kessler, 2000). Further analyses will
focus on the role of co-morbidity in the predic-
tion of (further) mental disorders, impairment
and reduced quality of life since co-morbidity
may be amodifiable risk factor for illness course,
future impairment and quality of life that can be
more easily targeted than sociodemographic
correlates of mental morbidity. Of special in-
terest in this context and suggesting need for
further research are the presented high associ-
ations of mental disorders and poor somatic
health status.
Conclusions for future analyses and studies
Further analyses will determine the impact of
mental disorders both on individual suffering
and health related quality of life, and on direct
and indirect societal costs of disorders (health
care costs, loss of work productivity). Future
studies should be designed to investigate modi-
fiable risk factors of illness onset and course
in greater detail, including developmental and
genetic aspects (Wittchen, 1996b ; Kessler, 2000).
Further research on determinants of help seek-
ing and health care delivery is also needed since
pathways to adequate mental health care seem
not only to be disorder-specific or determined
by severity of a condition, but also by other
factors (e.g. knowledge about mental disorders
in patients or in primary care physicians, or
limitations within a health care system).
Kessler et al. (2002) suggest, on the basis of
findings from the World Mental Health surveys
on the distinction of generalized anxiety dis-
order from depression, that more comprehensive
analyses within the complex area of co-mor-
bidity are strongly needed in psychiatric epi-
demiology. A better understanding of patterns
of comorbidity is relevant for diagnostic and
nosological reasons and aetiological research on
mental disorders on the one hand, and for
the improvement of prevention and treatment
strategies on the other hand, since co-morbidity
affects onset, course and severity of the single
disorders involved. In particular investigations
on comorbidity with somatic conditions will
enhance knowledge on health and illness as
comprehensive concepts.
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